Loss of SDHB Promotes Dysregulated Iron Homeostasis, Oxidative Stress, and Sensitivity to Ascorbate
Judith Goncalves(Stanford University), Judith Favier(Inserm), Anne‐Paule Gimenez‐Roqueplo(Délégation Paris 5), Sophie Moog(Institut Gustave Roussy), Cynthia L. Andoniadou(University Hospital Carl Gustav Carus), Daniel A. Tennant(University of Birmingham), Géraldine Gentric(Inserm), Charlotte Lussey‐Lepoutre(Inserm), Alexander P. Morrell(King's College London), Alpesh Thakker(The Edgbaston Hospital), Sebastian Müller(Freie Universität Berlin), Paule Bénit(Inserm), Katarína Kľučková(The Edgbaston Hospital), Aurélie Morin(Centre National de la Recherche Scientifique), Theodora J. Stewart(London Metropolitan University), Fatima Mechta‐Grigoriou(Inserm), Éric Letouzé(Centre National de la Recherche Scientifique), Jennie Roberts(AstraZeneca (United Kingdom)), Lisa A. Vettore(The Edgbaston Hospital), Raphaël Rodriguez(Centre National de la Recherche Scientifique)
Cited by 64
Related Papers
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial
|The Lancet Oncology|2014|1.7k
Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer
|Cancer Cell|2018|1.7k
The ratio of the nucleon structure functions F2N for iron and deuterium
|Physics Letters B|1983|1.1k
Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma
|Cancer Cell|2017|791
SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma
|Cancer Cell|2013|772